Atlas FDA

Belotero Balance + Lidocaine Dermal Filler, Belotero Balance Dermal Filler

FDA premarket approval P090016/S045 · decided 2021-12-08

Approval details

PMA number
P090016
Supplement
S045
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Belotero Balance + Lidocaine Dermal Filler, Belotero Balance Dermal Filler
Generic name
Implant, dermal, for aesthetic use
Applicant
Merz North America, Inc.
Date received
2021-05-05
Decision date
2021-12-08
Days to decision
217 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Franksville, WI
Statement
Approval for a change from traditional sterility testing to parametric release strategy for product release of Belotero Balance (BB) and Belotero Balance + Lidocaine (BBL).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
DESCRIBE PFD Patch (K172689)Merz North America, Inc.2017-11-29